Transient receptor potential ankyrin 1 (TRPA1)-mediated toxicity: friend or foe?

被引:14
|
作者
Alavi, Mohaddeseh Sadat [1 ]
Shamsizadeh, Ali [2 ]
Karimi, Gholamreza [3 ,4 ]
Roohbakhsh, Ali [3 ,4 ]
机构
[1] Mashhad Univ Med Sci, Psychiat & Behav Sci Res Ctr, Div Neurocognit Sci, Mashhad, Razavi Khorasan, Iran
[2] Rafsanjan Univ Med Sci, Physiol Pharmacol Res Ctr, Rafsanjan, Iran
[3] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Razavi Khorasan, Iran
关键词
TRPA1; toxicology; neurotoxicity; cold; pain; respiratory system; INDUCED INTESTINAL MUCOSITIS; UPPER RESPIRATORY-TRACT; TRPA1; ION-CHANNEL; NEUROGENIC INFLAMMATION; AIRWAY INFLAMMATION; NEUROPATHIC PAIN; BOTULINUM NEUROTOXIN; BENZOQUINONE IMINE; SENSORY IRRITATION; ORAL MUCOSITIS;
D O I
10.1080/15376516.2019.1652872
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Transient receptor potential (TRP) channels have been widely studied during the last decade. New studies uncover new features and potential applications for these channels. TRPA1 has a huge distribution all over the human body and has been reported to be involved in different physiological and pathological conditions including cold, pain, and damage sensation. Considering its role, many studies have been devoted to evaluating the role of this channel in the initiation and progression of different toxicities. Accordingly, we reviewed the most recent studies and divided the role of TRPA1 in toxicology into the following sections: neurotoxicity, cardiotoxicity, dermatotoxicity, and pulmonary toxicity. Acetaminophen, heavy metals, tear gases, various chemotherapeutic agents, acrolein, wood smoke particulate materials, particulate air pollution materials, diesel exhaust particles, cigarette smoke extracts, air born irritants, sulfur mustard, and plasticizers are selected compounds and materials with toxic effects that are, at least in part, mediated by TRPA1. Considering the high safety of TRPA1 antagonists and their efficacy to resolve selected toxic or adverse drug reactions, the future of these drugs looks promising.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 50 条
  • [21] Transient receptor potential ankyrin 1 (TRPA1) ion channel in the pathophysiology of peripheral diabetic neuropathy
    Koivisto, Ari
    Pertovaara, Antti
    SCANDINAVIAN JOURNAL OF PAIN, 2013, 4 (03) : 129 - 136
  • [22] Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human OA chondrocytes
    Nummenmaa, E.
    Hamalainen, M.
    Moilanen, L.
    Paukkeri, E-L
    Nieminen, R. M.
    Moilanen, T.
    Vuolteenaho, K.
    Moilanen, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (05) : 437 - 437
  • [23] Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human vagina
    S Ückert
    J E Sonnenberg
    K Albrecht
    M A Kuczyk
    P Hedlund
    International Journal of Impotence Research, 2015, 27 : 16 - 19
  • [24] TRPA1 AS A FACTOR AND DRUG TARGET IN OSTEOARTHRITIS: TRPA1 (TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1) MEDIATES INTERLEUKIN-6 EXPRESSION IN CHONDROCYTES
    Nummenmaa, E.
    Hamalainen, M.
    Pemmari, A.
    Moilanen, L. J.
    Nieminen, R. M.
    Moilanen, T.
    Vuolteenaho, K.
    Moilanen, E.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S124 - S124
  • [25] Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice
    Ádám Horváth
    Valéria Tékus
    Melinda Boros
    Gábor Pozsgai
    Bálint Botz
    Éva Borbély
    János Szolcsányi
    Erika Pintér
    Zsuzsanna Helyes
    Arthritis Research & Therapy, 18
  • [26] Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice
    Horvath, Adam
    Tekus, Valeria
    Boros, Melinda
    Pozsgai, Gabor
    Botz, Balint
    Borbely, Eva
    Szolcsanyi, Janos
    Pinter, Erika
    Helyes, Zsuzsanna
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [27] TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1 (TRPA1) AS A FACTOR AND DRUG TARGET IN OSTEOARTHRITIS: TRPA1 MEDIATES FIBROBLAST GROWTH FACTOR 2 EXPRESSION IN CHONDROCYTES
    Nummenmaa, E.
    Hamalainen, M.
    Pemmari, A.
    Moilanen, L. J.
    Nieminen, R.
    Moilanen, T.
    Vuolteenaho, K.
    Moilanen, E.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S377 - S377
  • [28] The Role of Transient Receptor Potential Ankyrin-1 (TRPA1) in Chronic Itch in Atopic Dermatitis (AD)
    Min-Hee, O. H.
    Lou, Hongfei
    Myers, Allen
    Zhu, Zhou
    Zheng, Tao
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB103 - AB103
  • [29] The blockade of transient receptor potential ankyrin 1 (TRPA1) protects against PTZ-induced seizure
    Heydari, Fatemeh Sadat
    Valokola, Mahmoud Gorji
    Mehri, Soghra
    Abnous, Khalil
    Roohbakhsh, Ali
    METABOLIC BRAIN DISEASE, 2023, 38 (02) : 621 - 630
  • [30] The blockade of transient receptor potential ankyrin 1 (TRPA1) protects against PTZ-induced seizure
    Fatemeh Sadat Heydari
    Mahmoud Gorji Valokola
    Soghra Mehri
    Khalil Abnous
    Ali Roohbakhsh
    Metabolic Brain Disease, 2023, 38 : 621 - 630